Home › Funds › Sio Capital Management, LLC › IMNM
Sio Capital Management, LLC position in IMNM
IMMUNOME INC · Health Care
Sio Capital Management, LLC reported holding 124,168 shares of IMNM (IMMUNOME INC) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 0.44% of its reported portfolio and ranking #43 among its reported holdings. Sio Capital Management, LLC has disclosed IMNM holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sio Capital Management, LLC's IMNM position evolved
Sio Capital Management, LLC first disclosed a stake in IMNM in Q1 2026 at 165,110 shares (US$3.6M). Across 2 filings, Sio Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 124,168 shares valued at US$2.6M — a reduction of -40,942 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 165.11K | $3.61M | New |
| Q2 2026 | 124.17K | $2.63M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMNM and 13F data
IMNM (IMMUNOME INC) is a Health Care company. 49 other funds we track also report a position in IMNM — the largest reported positions include Redmile Group, LLC (US$104.1M), Enavate Sciences GP, LLC (US$76.6M), SILVERARC CAPITAL MANAGEMENT, LLC (US$42.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMNM
- Redmile Group, LLC 4.91M sh · $104.08M · Q2 2026
- Enavate Sciences GP, LLC 3.61M sh · $76.58M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 2.02M sh · $42.74M · Q2 2026
- Sofinnova Investments, Inc. 1.72M sh · $36.45M · Q2 2026
- READYSTATE ASSET MANAGEMENT LP 1.61M sh · $34.03M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 732.51K sh · $15.52M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 714.55K sh · $15.14M · Q2 2026
- Parkman Healthcare Partners LLC 594.20K sh · $12.59M · Q2 2026
- ALERUS FINANCIAL NA 383.42K sh · $8.12M · Q2 2026
- Atom Investors LP 297.49K sh · $6.30M · Q2 2026
More on Sio Capital Management, LLC
FAQ
How long has Sio Capital Management, LLC held IMNM?
Sio Capital Management, LLC has disclosed IMNM holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Sio Capital Management, LLC's current position in IMNM?
As of Q2 2026, Sio Capital Management, LLC holds 124.17K shares of IMNM (IMMUNOME INC), valued at $2.63M, representing 0.44% of its reported portfolio and ranking #43.
Has Sio Capital Management, LLC been buying or selling IMNM?
In the latest 13F filing (Q2 2026), Sio Capital Management, LLC reduced its position in IMNM.
Which other funds hold IMNM?
Other major institutional holders of IMNM include Redmile Group, LLC, Enavate Sciences GP, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.